Siam Bioscience reports record profit after COVID vaccine deal with AstraZeneca Ruchika Sharma29 Aug 2022 10:45 AM ISTBangkok: Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began...
AstraZeneca gets Japenese nod for Ultomiris to treat generalised myasthenia gravis Ruchika Sharma29 Aug 2022 9:30 AM ISTgMG is a rare, debilitating, chronic, autoimmune neuromuscular disease that leads to a loss of muscle function and severe weakness.
AstraZeneca, MSD get Japenese nod for breast cancer drug Lynparza Ruchika Sharma28 Aug 2022 11:45 AM ISTBreast cancer is the most diagnosed cancer worldwide with an estimated 2.3 million patients diagnosed in 2020.
AstraZeneca may not stay in vaccine business in long run: CEO Ruchika Sharma24 Aug 2022 2:57 PM ISTAstraZeneca is also looking for bolt-on acquisitions, including small and mid-sized companies specialising in oncology and cardiovascular treatments,...
AstraZeneca anticancer drug Trastuzumab Deruxtecan protocol amendment proposal approved by CDSCO panel Roshni Dhar23 Aug 2022 6:30 PM ISTBased on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug Standard Control...
Health Bulletin 23/August/2022 Roshni Dhar23 Aug 2022 5:18 PM ISTHere are the top health news for the day:'Tomato fever' misleading colloquial name for hand, foot and mouth disease Medical professional has informed...
AstraZeneca India breast cancer drug lynparza gets DCGI okay Isra Zaman22 Aug 2022 5:15 PM ISTAstraZeneca India, a science-led biopharmaceutical company, has announced that it has received a Drugs Controller General of India (DCGI) approval to...
CDSCO approves AstraZeneca Anticancer Drug Trastuzumab Deruxtecan Protocol Amendment Dr. Divya Colin21 Aug 2022 2:00 PM ISTNew Delhi: Based on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug...
DCGI nod to AstraZeneca India breast cancer drug Lynparza Ruchika Sharma20 Aug 2022 11:49 AM ISTEarly breast cancer is defined as the cancer confined to the breast with or without regional lymph node involvement and the absence of distant...
Thermo Fisher Scientific secures USFDA nod for Oncomine Dx Target Test for lung cancers with HER2 mutations Ruchika Sharma15 Aug 2022 12:00 PM ISTThe Oncomine Dx Target Test is designed to simultaneously evaluate 23 genes associated with NSCLC.
AstraZeneca concludes acquisition of TeneoTwo Ruchika Sharma15 Aug 2022 11:00 AM ISTAstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
AstraZeneca, Daiichi Sankyo get USFDA accelerated nod for Enhertu for HER2 Mutant Non-small Cell Lung Cancer Ruchika Sharma14 Aug 2022 3:30 PM ISTEnhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi...
